Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 2Oligodendroglioma 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Leukemia 1Central Nervous System Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Intraductal, Noninfiltrating 1Astrocytoma 1Advanced Breast Cancer 1

Interventions

Temozolomide 7Radiotherapy 5Vincristine 3Cisplatin 3Carmustine 3Carboplatin 3Methotrexate 2Cyclophosphamide 2Chlorotoxin 2lonafarnib 1Verteporfin 1Thiotepa 1Surgical Procedures, Operative 1Peripheral Blood Stem Cell Transplantation 1Pemetrexed 1Metabolism 1In Situ Hybridization, Fluorescence 1Immunohistochemistry 1Gelclair 1Etoposide 1Ethanol 1Arsenic Trioxide 1Aminolevulinic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Oligodendroglioma × In Situ Hybridization, Fluorescence × Clear all
NCT00360945 2013-09-17

Cisplatin and Temozolomide in Treating Young Patients With Malignant Glioma

National Cancer Institute (NCI)

Phase 2 Unknown
87 enrolled
CNS

Astrocytoma, Oligodendroglioma, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡